iifl-logo

Vilin Bio Med Ltd Share Price

32.5
(4.84%)
Apr 24, 2025|09:39:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open32
  • Day's High32.5
  • 52 Wk High31
  • Prev. Close31
  • Day's Low29.45
  • 52 Wk Low 15.4
  • Turnover (lac)15.6
  • P/E258.33
  • Face Value10
  • Book Value16.37
  • EPS0.12
  • Mkt. Cap (Cr.)45.34
  • Div. Yield0
View All Historical Data
No Records Found

Vilin Bio Med Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

32

Prev. Close

31

Turnover(Lac.)

15.6

Day's High

32.5

Day's Low

29.45

52 Week's High

31

52 Week's Low

15.4

Book Value

16.37

Face Value

10

Mkt Cap (₹ Cr.)

45.34

P/E

258.33

EPS

0.12

Divi. Yield

0

Vilin Bio Med Ltd Corporate Action

23 Jan 2025

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

22 Aug 2024

12:00 AM

BookCloser

arrow

22 Aug 2024

12:00 AM

AGM

Announcement Date: 22 Aug, 2024

arrow

Vilin Bio Med Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Vilin Bio Med Ltd SHAREHOLDING SNAPSHOT

24 Apr, 2025|10:06 AM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 64.08%

Foreign: 0.00%

Indian: 64.08%

Non-Promoter- 35.91%

Institutions: 0.00%

Non-Institutions: 35.91%

Custodian: 0.00%

Share Price

Vilin Bio Med Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2024Mar-2023Mar-2022Mar-2021

Equity Capital

13.95

9.95

3.3

3.3

Preference Capital

0

0

0

0

Reserves

8.89

0.73

4.1

4.06

Net Worth

22.84

10.68

7.4

7.36

Minority Interest

View Balance Sheet

No Record Found

View Profit & Loss

No Record Found

View Cash Flow

No Record Found

View Ratios

No Record Found

Vilin Bio Med Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceutical Industries Ltd

SUNPHARMA

1,788.8

136.254,29,217.031,181.050.755,985.3398.33

Divis Laboratories Ltd

DIVISLAB

5,924.5

75.781,57,100.325940.512,297513.62

Cipla Ltd

CIPLA

1,533.7

26.611,23,852.121,438.150.854,134.87360.73

Torrent Pharmaceuticals Ltd

TORNTPHARM

3,332.4

61.861,12,844.494850.842,330222.38

Mankind Pharma Ltd

MANKIND

2,545.5

54.31,05,003.3416.3802,396.57334.17

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Vilin Bio Med Ltd

Management

Register Office

Registrar Office

Independent Director

Veerareddy Vallapureddy

Independent Director

Rakesh Kumar Chandak

Managing Director

S Viswa Prasad

Whole-time Director

Anuj Bajpai

Non Executive Director

S Padmaja Kalyani

Company Sec. & Compli. Officer

Ashdeep Kaur

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Vilin Bio Med Limited was originally incorporated on June 29, 2005, which commenced business on July 11, 2005 issued by Registrar of Companies, Andhra Pradesh, Hyderabad. The Company started its first commercial production in year 2006. In 2007, the Company expanded the Phase 2 for Beta Lactum facility with 16000 sft for Tablet, Capsule and Dry Syrup sections. In 2010, it acquired more than 1000 molecules Drug Approvals with different strengths in therapeutics of Diabetic, Neuro and Cardio. The Company added the Sachet section in Non-Beta Lactum facility in 2014. The Company allotted a fresh issue of 40,00,000 Equity Shares of Rs 10/- each by its Initial Public Offering by raising funds aggregating to Rs 12 Crore on June 7, 2023 to the Public.At present, Company is engaged in domestic business of manufacturing Pharmaceuticals products and the Manufacturing Unit is located in Roorkee, in the State of Uttarakhand. In order to maintain competitiveness and to further the cause of Healthcare, Company has laid a R&D Foundation and state of the art Manufacturing Facility in Roorkee. The major products for manufacturing dosage forms consist of Oral Liquid (Syrups/Suspensions/Dry Powders (eta & Non eta-Lactam), Tablets & Capsules (eta & Non eta-Lactam) and External Preparations.Ointments along with similar products like Creams, Lotions, Gels or Pates are certain formulations primarily designed to be applied to the skin. Beta-Lactam are a group of medicines that are used to treat inf
Read More

Company FAQs

What is the Vilin Bio Med Ltd share price today?

The Vilin Bio Med Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹32.5 today.

What is the Market Cap of Vilin Bio Med Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Vilin Bio Med Ltd is ₹45.34 Cr. as of 24 Apr ‘25

What is the PE and PB ratio of Vilin Bio Med Ltd?

The PE and PB ratios of Vilin Bio Med Ltd is 258.33 and 1.89 as of 24 Apr ‘25

What is the 52 Week High and Low of Vilin Bio Med Ltd?

The 52-week high/low is the highest and lowest price at which a Vilin Bio Med Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Vilin Bio Med Ltd is ₹15.4 and ₹31 as of 24 Apr ‘25

What is the CAGR of Vilin Bio Med Ltd?

Vilin Bio Med Ltd's CAGR for 5 Years at N/I%, 3 Years at N/I%, 1 Year at 51.59%, 6 Month at 43.85%, 3 Month at 65.78% and 1 Month at 60.62%.

What is the shareholding pattern of Vilin Bio Med Ltd?

The shareholding pattern of Vilin Bio Med Ltd is as follows:
Promoters - 64.09 %
Institutions - 0.00 %
Public - 35.91 %

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.